{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:15:33Z","timestamp":1790615733754,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"anjing Health Planning Commission"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.imbio.2019.08.008","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T11:28:21Z","timestamp":1566559701000},"page":"786-791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["NLRP3 inflammasome inhibitor glyburide expedites diabetic-induced impaired fracture healing"],"prefix":"10.1016","volume":"224","author":[{"given":"Xilan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.imbio.2019.08.008_bib0005","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes","year":"2014","journal-title":"Diabetes Care"},{"issue":"Suppl 27","key":"10.1016\/j.imbio.2019.08.008_bib0010","first-page":"5","article-title":"Diagnosis, classification, and pathogenesis of diabetes mellitus","volume":"62","author":"Lebovitz","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.imbio.2019.08.008_bib0015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-0584-6223","article-title":"Definition, Classification and diagnosis of diabetes mellitus","volume":"126","author":"Petersmann","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.imbio.2019.08.008_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.imbio.2019.08.008_bib0025","article-title":"Bone disorders associated with diabetes mellitus and its treatments","author":"Cortet","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.imbio.2019.08.008_bib0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/joim.12725","article-title":"Type 2 diabetes mellitus and bone","volume":"283","author":"Compston","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.imbio.2019.08.008_bib0035","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.2169\/internalmedicine.0905-18","article-title":"Diabetes mellitus-induced bone fragility","volume":"57","author":"Kanazawa","year":"2018","journal-title":"Intern. Med."},{"key":"10.1016\/j.imbio.2019.08.008_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bone.2018.05.030","article-title":"Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes","volume":"114","author":"Karim","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.imbio.2019.08.008_bib0045","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2019.08.008_bib0050","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.CIR.0000158483.13093.9D","article-title":"Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation","volume":"111","author":"Dandona","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.imbio.2019.08.008_bib0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11914-015-0286-8","article-title":"Diabetes and its effect on bone and fracture healing","volume":"13","author":"Jiao","year":"2015","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.imbio.2019.08.008_bib0060","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2019.08.008_bib0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v30.i5.50","article-title":"Inflammasomes and their activation","volume":"30","author":"Khare","year":"2010","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.imbio.2019.08.008_bib0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.imbio.2019.08.008_bib0075","first-page":"737","article-title":"The pathogenic role of NLRP3 inflammasome activation in inflammatory bowel diseases of both mice and humans","volume":"11","author":"Liu","year":"2017","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.imbio.2019.08.008_bib0080","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.taap.2016.12.008","article-title":"Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth","volume":"315","author":"Yang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.imbio.2019.08.008_bib0085","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.2337\/db18-0340","article-title":"FOXO1 deletion reverses the effect of diabetic-induced impaired fracture healing","volume":"67","author":"Alharbi","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.imbio.2019.08.008_bib0090","doi-asserted-by":"crossref","first-page":"15037","DOI":"10.1038\/boneres.2015.37","article-title":"Analysis of new bone, cartilage, and fibrosis tissue in healing murine allografts using whole slide imaging and a new automated histomorphometric algorithm","volume":"4","author":"Zhang","year":"2016","journal-title":"Bone Res."},{"key":"10.1016\/j.imbio.2019.08.008_bib0095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2337\/diab.33.9.838","article-title":"Mechanism of improvement in glucose metabolism after chronic glyburide therapy","volume":"33","author":"Simonson","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/j.imbio.2019.08.008_bib0100","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/cid\/ciq192","article-title":"Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis","volume":"52","author":"Koh","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imbio.2019.08.008_bib0105","doi-asserted-by":"crossref","DOI":"10.2174\/0929866526666190301114012","article-title":"Repurposing glyburide as antileishmanial agent to fight against leishmaniasis","author":"Rub","year":"2019","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.imbio.2019.08.008_bib0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/ten.teb.2008.0038","article-title":"Modulation of the inflammatory response for enhanced bone tissue regeneration","volume":"14","author":"Mountziaris","year":"2008","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.imbio.2019.08.008_bib0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mce.2006.09.008","article-title":"Sulfatide increases adiponectin and decreases TNF-alpha, IL-6, and IL-8 in human adipose tissue in vitro","volume":"263","author":"Bruun","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.imbio.2019.08.008_bib0120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jemt.10370","article-title":"Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption","volume":"61","author":"Sasaki","year":"2003","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.imbio.2019.08.008_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2302\/kjm.52.1","article-title":"Differentiation and function of osteoclasts","volume":"52","author":"Miyamoto","year":"2003","journal-title":"Keio J. Med."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298519301950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298519301950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:45:14Z","timestamp":1759250714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298519301950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0171298519301950"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2019.08.008","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 inflammasome inhibitor glyburide expedites diabetic-induced impaired fracture healing","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2019.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}